These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2233357)

  • 1. Use of WEB 2086 and WEB 2170 as platelet-activating factor antagonists.
    Casals-Stenzel J; Heuer HO
    Methods Enzymol; 1990; 187():455-65. PubMed ID: 2233357
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking.
    Lehr HA; Weyrich AS; Saetzler RK; Jurek A; Arfors KE; Zimmerman GA; Prescott SM; McIntyre TM
    J Clin Invest; 1997 May; 99(10):2358-64. PubMed ID: 9153277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thienotriazolodiazepines as platelet-activating factor antagonists. Steric limitations for the substituent in position 2.
    Walser A; Flynn T; Mason C; Crowley H; Maresca C; O'Donnell M
    J Med Chem; 1991 Apr; 34(4):1440-6. PubMed ID: 2016721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
    Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J
    Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The thieno-triazolodiazepine WEB 2086 inhibits platelet aggregation and ATP release from porcine platelets induced by platelet activating factor (PAF).
    Griffin KJ; Levy JV
    Thromb Res; 1988 Jul; 51(2):219-23. PubMed ID: 3187959
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.
    Stewart AG; Dusting GJ
    Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of platelet activating factor in airway inflammation, airway hyperresponsiveness, and pulmonary function in monkeys.
    Gundel RH; Letts LG; Wegner CD
    Ann N Y Acad Sci; 1991; 629():205-16. PubMed ID: 1952550
    [No Abstract]   [Full Text] [Related]  

  • 10. 1-O-hexadecyl-2-metoxy-glycero-3-phosphatidylcholine--a methoxy ether lipid inhibiting platelet activating factor-induced platelet aggregation and neutrophil oxidative metabolism.
    Le Blanc K; Samuelsson J; Brohult J; Berg A; Palmblad J
    Biochem Pharmacol; 1995 May; 49(11):1577-82. PubMed ID: 7786298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G.
    Ferrer-Lopez P; Renesto P; Schattner M; Bassot S; Laurent P; Chignard M
    Am J Physiol; 1990 Jun; 258(6 Pt 1):C1100-7. PubMed ID: 2360620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits.
    Montrucchio G; Alloatti G; Mariano F; Lupia E; Lucchina PG; Musso E; Emanuelli G; Camussi G
    Circ Res; 1993 Mar; 72(3):658-70. PubMed ID: 8381725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro.
    Hirafuji M; Shinoda H
    Br J Pharmacol; 1991 Jun; 103(2):1333-8. PubMed ID: 1884095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell adhesion by membrane-bound paf-acether.
    Ninio E; Leyravaud S; Bidault J; Jurgens P; Benveniste J
    Int Immunol; 1991 Nov; 3(11):1157-63. PubMed ID: 1760410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO; Casals-Stenzel J; Muacevic G; Weber KH
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of neutrophil respiratory burst and degranulation responses to platelet-activating factor by antagonists WEB 2086, CV 6209 and CV 3988.
    Bates EJ; Harvey DP; Ferrante A
    Int Arch Allergy Immunol; 1992; 97(1):50-6. PubMed ID: 1582698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of hetrazepine PAF antagonists in preclinical models of asthma.
    Heuer HO
    Agents Actions Suppl; 1991; 34():229-45. PubMed ID: 1793067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of platelet activating factor on rat platelets in vivo.
    Klee A; Schmid-Schönbein GW; Seiffge D
    Eur J Pharmacol; 1991 Dec; 209(3):223-30. PubMed ID: 1797563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity studies on triazolothienodiazepine derivatives as platelet-activating factor antagonists.
    Miyazawa S; Okano K; Shimomura N; Clark RS; Kawahara T; Asano O; Yoshimura H; Miyamoto M; Sakuma Y; Muramoto K
    Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3215-20. PubMed ID: 1814614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAF antagonistic activity of some thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines.
    Tahara T; Mikashima H; Terasawa M; Maruyama Y
    Chem Pharm Bull (Tokyo); 1987 May; 35(5):2119-21. PubMed ID: 3664818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.